PhoreMost Awarded £1.4M Innovate UK Funding to Develop Lead Oncology Programme
Advertisement
PhoreMost Ltd announced that it has been selected to receive a funding award of £1.4M (approximately $2.14M USD) from the UK’s innovation agency, Innovate UK, to develop its lead oncology programme targeting mutant KRAS cancers.
Based on PhoreMost’s proprietary Protein Interference technology, the Company has developed ‘Site-Seeker’, a next-generation phenotypic screening platform that can identify the best new targets for drug development and, crucially, how to drug them. PhoreMost’s lead therapeutic programme has identified drug candidates to a novel synthetic-lethal target for KRAS. The Innovate UK funding will support development of this programme through phases of lead optimisation and candidate selection, with a longer aim to create a drug that may be tested in human clinical trials.
“We are pleased to receive funding from Innovate UK in support of our lead programme,” commented Dr Chris Torrance, CEO of PhoreMost. “The expert reviews conducted by Innovate UK provide independent, competitive validation of our lead programme development strategy, and the award funds will support our business aims to create novel therapies for cancer patients who have limited treatment options.”
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Environmentally friendly Filter membrane renders viruses harmless - New filter membrane is highly efficient at filtering and inactivating a wide variety of air-borne and water-borne viruses: ETH spin-off holds the patent on this new technology
Ready-to-use recipe for turning plant waste into gasoline
Proteros achieves growth rate of more than 30 % in 2009 and announces expansion of commercial organization in USA and Japan
Addex Pharmaceuticals Announces Board Changes - Vincent Lawton appointed to Vice-Chairman
High coronary calcium score may signal increased risk of cancer, kidney and lung disease
Viragen Reports Advancement in Avian Transgenics Biomanufacturing - Anti-cancer Antibody Expressed in Rooster